What is Evommune 's EBITDA?

Evommune (EVMN) reported EBITDA of -$678.22K in Q1 2026.

How has Evommune 's EBITDA changed year-over-year?

Evommune 's EBITDA decreased by 2521.2% year-over-year, from -$25.88K to -$678.22K.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Evommune EVMN EBITDA

EBITDA at other companies

Bausch + LombBLCO

$134M+483%

BillionToOne, Inc. BLLN

$19.57M+3,849%

Perrigo CompanyPRGO

-$289M-328%

PfizerPFE

——

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Calculated from Evommune ’s reported figures.

−$682.8Kebit+

$4.6KDepreciation Depletion & Amortization

=-$678.22K

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's EBITDA?: Evommune (EVMN) reported EBITDA of -$678.22K in Q1 2026.
How has Evommune 's EBITDA changed year-over-year?: Evommune 's EBITDA decreased by 2521.2% year-over-year, from -$25.88K to -$678.22K.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.